These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28786420)

  • 1. Cardiovascular toxicities of systemic treatments of prostate cancer: is oestrogen to the rescue?
    Veccia A; Maines F; Caffo O
    Nat Rev Urol; 2017 Sep; 14(9):1. PubMed ID: 28786420
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular toxicities of systemic treatments of prostate cancer: oestrogen to the rescue?
    Shah SIA; Wilson HCP; Abel PD
    Nat Rev Urol; 2017 Sep; 14(9):1. PubMed ID: 28786419
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular complications of oestrogen treatment in prostatic carcinoma (author's transl)].
    Héritier P; Hessler D
    Ther Umsch; 1978 Oct; 35(10):841-4. PubMed ID: 705679
    [No Abstract]   [Full Text] [Related]  

  • 4. Oestrogens: are they really dangerous? Groupe Coopératif d'étude sur le Cancer de la Prostate.
    Prog Clin Biol Res; 1987; 243B():437-8. PubMed ID: 3659036
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular toxicities of therapy for genitourinary malignancies.
    Narayan V; Vaughn DJ; Ky B
    Urol Oncol; 2020 Mar; 38(3):121-128. PubMed ID: 31104977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular accidents of estrogen therapy for prostatic cancer metastases].
    Jurascheck F
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):400-2. PubMed ID: 4804405
    [No Abstract]   [Full Text] [Related]  

  • 7. I'm on androgen deprivation therapy (ADT) for prostate cancer. I've heard that it may cause heart problems. Should I be worried?
    Johns Hopkins Med Lett Health After 50; 2010 May; 22(3):8. PubMed ID: 20518140
    [No Abstract]   [Full Text] [Related]  

  • 8. [Apropos of hormone-independent cancer of the prostate].
    Chauvin HF
    J Urol Nephrol (Paris); 1967 Mar; 73(3):334-6. PubMed ID: 6054950
    [No Abstract]   [Full Text] [Related]  

  • 9. Orchidectomy and oestrogen therapy revisited.
    Iversen P
    Eur Urol; 1998; 34 Suppl 3():7-11. PubMed ID: 9854189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New drugs: Estracyt].
    Urologe A; 1974 Mar; 13(2):100. PubMed ID: 4832064
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular risks induced by estrogens prescribed at low doses. 208 years of observation--137 patients].
    Chevret S; Chastang C
    Prog Urol; 1991 Apr; 1(2):281-5. PubMed ID: 1844829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens in the treatment of prostate cancer.
    Cox RL; Crawford ED
    J Urol; 1995 Dec; 154(6):1991-8. PubMed ID: 7500443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.
    Meade TW
    Br Med J (Clin Res Ed); 1986 Oct; 293(6552):953-4. PubMed ID: 3094728
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular risk during androgen deprivation therapy for prostate cancer.
    Jones TH
    BMJ; 2011 May; 342():d3105. PubMed ID: 21610041
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
    Kijima T; Fujii Y; Yokoyama M; Ishioka J; Matsuoka Y; Numao N; Saito K; Koga F; Masuda H; Kawakami S; Kihara K
    BJU Int; 2012 Oct; 110(8):1149-55. PubMed ID: 22369348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of oestrogens on cardiovascular risk factors in patients with carcinoma of the prostate (author's transl)].
    Varenhorst E; Carlström K; Karlberg BE; Risberg B; Wallentin L; Wranne B
    Urologe A; 1982 Jan; 21(1):34-8. PubMed ID: 6805122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen therapy in prostatic cancer.
    Smith PH; Akdas A
    Scand J Urol Nephrol Suppl; 1980; 55():91-4. PubMed ID: 6938043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular effects of estrogen in prostatic cancer].
    Hedlund PO
    Lakartidningen; 1981 May; 78(22):2215-7. PubMed ID: 7196479
    [No Abstract]   [Full Text] [Related]  

  • 19. Oestrogen therapy and prostatic cancer.
    Br Med J; 1968 Apr; 2(5598):131-2. PubMed ID: 5641970
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.
    Hedlund PO; Gustafson H; Sjögren S
    Scand J Urol Nephrol Suppl; 1980; 55():103-5. PubMed ID: 6938012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.